Discover trends, market shifts, and competitive outlooks for the candida infection testing industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Are the Projected Market Size and Growth Rates for the Candida Infection Testing Market From 2025 To 2029?

In the past few years, there has been a robust growth in the market size of candida infection testing. The market is anticipated to expand from $15.69 billion in 2024 to $16.72 billion in 2025, reflecting a compound annual growth rate (CAGR) of 6.6%. Factors such as the escalating cases of candida infections, improved diagnostics and increased awareness, growth of healthcare infrastructure, a surge in the number of hospital-acquired infections, and an uptick in funding for research have contributed to the historical growth period.

The market for candida infection testing is predicted to undergo significant expansion in the coming years, reaching a valuation of $21.29 billion by 2029, with a compound annual growth rate (CAGR) of 6.2%. The anticipated growth during the forecast period can be credited to the appearance of new strains of candida, increased cognizance of fungal diseases, greater accessibility to healthcare services, an older population, and heightened knowledge of preventative healthcare. Key trends expected during this period will be advancements in molecular diagnostics, the integration of digital health technologies, application of Artificial Intelligence, the inclusion of machine learning, and personalized medication.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19356&type=smp

Which Primay Drivers Are Accelerating Growth in the Candida Infection Testing Market?

The escalating occurrence of yeast infections is anticipated to boost the expansion of the candida infection testing market. These types of infections are fungal in nature, arising from an excessive growth of candida and often inflict areas such as the mouth, genitals, and skin. Symptoms generally include itching, redness, and discomfort. The primary cause of these infections is an overproduction of the candida fungus, which can result from imbalances in natural body bacteria, weakened immunity, or hormonal fluctuations. Candida infection testing is employed in these cases to precisely identify the overgrowth of candida, aiding medical professionals to confirm the infection and provide suitable treatment. For instance, as reported by GOV.UK, a government agency in the UK, in 2022, the ratio of bloodstream infections (BSI) instigated by yeast in England was 4.0 per 100,000 population. This denoted a 4% rise in comparison to 2021. Hence, the escalating occurrence of yeast infections will fuel the expansion of the candida infection testing market.

Which Primary Segments of the Candida Infection Testing Market Are Driving Growth and Industry Transformations?

The candida infection testingmarket covered in this report is segmented –

1) By Type: Invasive Candidiasis, Candidemia

2) By Test Type: Vaginal pH Test, Nucleic Acid Amplification Testing (NAAT), Microbiome Test

3) By Application: Hospital, Laboratory

Subsegments:

1) By Invasive Candidiasis: Tissue Biopsy Testing, Urine Culture Testing, Blood Culture Testing

2) By Candidemia: Blood Tests, Serological Testing, Molecular Testing

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=19356&type=smp

Which Regions Are Key Players in the Growth of the Candida Infection Testing Market?

North America was the largest region in the candida infection testing market in 2024. The regions covered in the candida infection testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Technological Trends Are Reshaping the Candida Infection Testing Industry Dynamics?

Significant entities in the candida infection testing industry are concentrating on the creation of technologically advanced applications, such as a completely automated Polymerase Chain Reaction (PCR) quick test for candida, with the aim of increasing diagnostic precision and boosting patients’ health outcomes. This fully automated PCR rapid test for candida detection is a complex diagnostic technology that employs PCR to rapidly and efficiently discern the existence of candida species in clinical specimens. For example, Bosch Healthcare Solutions GmbH, a medical technology firm based in Germany, in May 2024, introduced a PCR test for Candida auris on the Vivalytic platform. This test provides fast, fully automated testing within an hour when care is needed. This improved technique is starkly different from conventional culture methods, often utilized in centralized labs and typically requiring one to three days, leading to delayed diagnosis and treatment. Specially developed for clinical applications, this test is incredibly beneficial for patients at high risk, allowing prompt diagnosis and treatment, critical in addressing the serious health threats posed by C. auris infections.

View the full report here:

https://www.thebusinessresearchcompany.com/report/candida-infection-testing-global-market-report

What Parameters Are Used to Define the Candida Infection Testing Market?

Candida infection testing refers to diagnostic procedures used to identify the presence of candida species, which are fungi that can cause infections in various parts of the body. These tests help determine the type and extent of the Candida infection, guiding appropriate treatment strategies.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19356

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model